Fatal or nonfatal myocardial infarction · CVD (ASCVD, HF, or both)
GLP‐1RA showed no clear difference in myocardial infarction (fatal or non‐fatal) compared with placebo (moderate certainty).
1 finding from 1 review
Fatal or nonfatal myocardial infarction · CVD (ASCVD, HF, or both)
DPP4i showed no clear difference in myocardial infarction (fatal or non‐fatal) compared with placebo (high certainty).
1 finding from 1 review
Fatal or nonfatal myocardial infarction · CVD (ASCVD, HF, or both)
SGLT2i showed no clear difference in myocardial infarction (fatal or non‐fatal) compared with placebo (high certainty).
1 finding from 1 review
Intervention not reported
Myocardial infarction (non‐fatal) · people with cardiovascular disease or at high risk of cardiovascular disease
The intervention probably leads to lower myocardial infarction (non‐fatal) (moderate certainty).
1 finding from 1 review
Intervention not reported
Fatal and non‐fatal myocardial infarction · Free‐living adults who were healthy, had established cardiovascular disease or risk factors for cardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatal or nonfatal myocardial infarction · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
clopidogrel plus aspirin probably leads to lower fatal and non‐fatal myocardial infarction compared with aspirin alone (moderate certainty).
1 finding from 1 review
Intervention not reported
Fatal or non‐fatal myocardial infarction ( · people with or at risk of cardiovascular disease
The intervention showed no clear difference in fatal or non‐fatal myocardial infarction ( (moderate certainty).
1 finding from 1 review
Fatal or nonfatal myocardial infarction · participants with UA/NSTEMI in the stent era
Routine invasive strategies showed no clear difference in death or non‐fatal Myocardial infarction compared with selective invasive strategies (conservative) (low certainty).
1 finding from 1 review
Intervention not reported
Non‐fatal myocardial infarction Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower non‐fatal myocardial infarction Long‐term (low certainty).
1 finding from 1 review
Fatal & Nonfatal myocardial infarction or reinfarction · patients with acute coronary syndrome
Statins showed no clear difference in fatal and non‐fatal myocardial infarction or reinfarction compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Fatal or nonfatal myocardial infarction · middle‐aged US male physicians
Vitamin C supplementation showed no clear difference in total myocardial infarction (fatal and non‐fatal) Physicians compared with placebo (low certainty).
1 finding from 1 review
Fatal or nonfatal myocardial infarction · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates probably leads to lower myocardial infarction (non‐fatal or fatal) during the treatment and… compared with control (moderate certainty).
2 findings from 1 review
Intervention not reported
ASCVD event, such as fatal or non‐fatal myocardial infarction or stroke. Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention showed no clear difference in ASCVD event, such as fatal or non‐fatal myocardial infarction or… (low certainty).
1 finding from 1 review
Stroke, myocardial infarction, or vascular death · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates probably leads to lower composite outcome of non‐fatal stroke, non‐fatal myocardial… compared with control (moderate certainty).
1 finding from 1 review
Intervention not reported
Coronary heart disease (death from cardiovascular causes and non‐fatal myocardial infarction) · Post‐menopausal women
The intervention probably leads to lower coronary heart disease (death from cardiovascular causes and… (moderate certainty).
1 finding from 1 review
Intervention not reported
Coronary heart disease (death from cardiovascular causes and non‐fatal myocardial infarction) · Post‐menopausal women
The intervention showed no clear difference in coronary heart disease (death from cardiovascular causes and… (high certainty).
1 finding from 1 review
Combined outcome of non‐fatal myocardial infarction, non‐fatal stroke, and total number of deaths · patients with acute coronary syndrome
Statins showed no clear difference in combined outcome of non‐fatal myocardial infarction, non‐fatal… compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Intervention not reported
Major cardiovascular events (cardiovascular mortality or non‐fatal myocardial infarction) at maximum · patients without heart failure
The intervention may leads to lower major cardiovascular events (cardiovascular mortality or non‐fatal… (low certainty).
1 finding from 1 review
Composite outcome of non‐fatal stroke, non‐fatal myocardial infarction, and vascular death without clofibrate · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates showed no clear difference in composite outcome of non‐fatal stroke, non‐fatal myocardial… compared with control (low certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in non‐fatal cardiovascular events (non‐fatal stroke, myocardial… compared with aspirin (moderate certainty).
1 finding from 1 review